182
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Ocular Adverse Events following Yellow Fever Vaccination: A Case Series

, MD, , MDORCID Icon, , MD, MBA, , MD, PhDORCID Icon, , MD, PhD, , MD, PhDORCID Icon & , MD, PhD show all
Pages 1425-1429 | Received 01 Jun 2020, Accepted 01 Feb 2021, Published online: 07 Apr 2021

References

  • Barrett ADT, Monath TP. Epidemiology and ecology of yellow fever virus. Adv Virus Res. 2003;61:291–315. doi:10.1016/S0065-3527(03)61007-9.
  • Paho. Epidemiological update yellow fever situation summary in the Americas; 2019. http://www.paho.org. Accessed February 22, 2019.
  • Ferreira C de C, Campi-Azevedo AC, Peruhype-Magalhāes V, et al. The 17D-204 and 17DD yellow fever vaccines: an overview of major similarities and subtle differences. Expert Rev Vaccines. 2018;17(1):79–90. doi:10.1080/14760584.2018.1406800.
  • Moysidis SN, Koulisis N, Patel VR, et al. The second blind spot: small retinal vessel vasculopathy after vaccination against Neisseria meningitidis and yellow fever. Retin Cases Br Reports. 2017;11(1):S18–S23. doi:10.1097/ICB.0000000000000391.
  • Biancardi AL, de Moraes HV. Anterior and intermediate uveitis following yellow fever vaccination with fractional dose: case reports. Ocul Immunol Inflamm. 2018;1–3. doi:10.1080/09273948.2018.1510529.
  • Campos WR, Cenachi SPF, Soares MS, et al. Vogt – Koyanagi – Harada -like disease following yellow fever vaccination Vogt – Koyanagi – Harada -like disease following yellow fever vaccination. Ocul Immunol Inflamm. 2019;1–4. doi:10.1080/09273948.2019.1661498.
  • Marinho PM, Nascimento H, Romano A, Muccioli C RB Jr. Diffuse uveitis and chorioretinal changes after yellow fever vaccination : a reemerging epidemic. Int J Retin Vitr. 2019;1–4. doi:10.1186/s40942-019-0180-0.
  • Voigt U, Baum U, Behrendt W, Hegemann S, Terborg C, Strobel J. Optikusneuritis nach impfung gegen hepatitis A, B und gelbfieber mit irreversiblem visusverlust. Klin Monbl Augenheilkd. 2001;218(10):688–690. doi:10.1055/s-2001-18392.
  • Stangos A, Zaninetti M, Petropoulos I, Baglivo E, Pournaras C. Multiple evanescent white dot syndrome following simultaneous hepatitis-A and yellow fever vaccination. Ocul Immunol Inflamm. 2006;14(5):301–304. doi:10.1080/09273940600932311.
  • Escott S, Tarabishy AB, Davidorf FH. Multifocal choroiditis following simultaneous hepatitis a, typhoid, and yellow fever vaccination. Clin Ophthalmol. 2013;7:363–365. doi:10.2147/OPTH.S37443.
  • Monath TP, Vasconcelos PFC. Yellow fever. J Clin Virol. 2015;64:160–173. doi:10.1016/j.jcv.2014.08.030.
  • Possas C, Lourenço-de-Oliveira R, Tauil PL, et al. Yellow fever outbreak in Brazil: the puzzle of rapid viral spread and challenges for immunisation. Mem Inst Oswaldo Cruz. 2018;113(10):e180278. doi:10.1590/0074-02760180278.
  • Tomashek KM, Challberg M, Nayak SU, Schiltz HF. Disease resurgence, production capability issues and safety concerns in the context of an aging population: is there a need for a new yellow fever vaccine? Vaccines (Basel). 2019;7(4):179. doi:10.3390/vaccines7040179.
  • Nnaji CA, Shey MS, Adetokunboh OO, Wiysonge CS. Immunogenicity and safety of fractional dose yellow fever vaccination: a systematic review and meta-analysis. Vaccine. 2020;38(6):1291–1301. doi:10.1016/j.vaccine.2019.12.018.
  • Silva ML, Martins MA, Espírito-Santo LR, et al. Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults. Vaccine. 2011;29(3):583–592. doi:10.1016/j.vaccine.2010.08.046.
  • Foster BS, Agahigian DD. Central serous chorioretinopathy associated with anthrax vaccination. Retina. 2004;24(4):624–625. http://www.ncbi.nlm.nih.gov/pubmed/15300091. Accessed June 25, 2018.
  • Rosen E. The significance of ocular complications following vaccination. Br J Ophthalmol. 1949;33(6):358–368. doi:10.1136/bjo.33.6.358.
  • Nicholson BP, Atchison E, Idris AA, Bakri SJ. Central serous chorioretinopathy and glucocorticoids: an update on evidence for association. Surv Ophthalmol. 2018;63(1):1–8. doi:10.1016/j.survophthal.2017.06.008.
  • Brattsand R, Linden M. Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. Aliment Pharmacol Ther. 1996;10(Suppl 2):81–90; discussion 91-2. http://www.ncbi.nlm.nih.gov/pubmed/8899106. Accessed February 22, 2019.
  • Wraith DC, Goldman M, Lambert PH. Vaccination and autoimmune disease: what is the evidence? Lancet. 2003;362(9396):1659–1666. doi:10.1016/S0140-6736(03)14802-7.
  • Cordero-Coma M, Salazar-Méndez R, Garzo-García I, Yilmaz T. Drug-induced uveitis. Expert Opin Drug Saf. 2015;14(1):111–126. doi:10.1517/14740338.2015.972363.
  • Agarwal M, Dutta Majumder P, Babu K, et al. Drug-induced uveitis: a review. Indian J Ophthalmol. 2020;68(9):1799–1807. doi:10.4103/ijo.IJO_816_20.
  • Lavezzo MM, Sakata VM, Morita C, et al. Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes. Orphanet J Rare Dis. 2016;11(1):29. doi:10.1186/s13023-016-0412-4.
  • Dogan B, Erol MK, Cengiz A. Vogt-Koyanagi-Harada disease following BCG vaccination and tuberculosis. Springerplus. 2016;5(1):603. doi:10.1186/s40064-016-2223-4.
  • Sood AB, O’Keefe G, Bui D, Jain N. Vogt-Koyanagi-Harada disease associated with Hepatitis B vaccination. Ocul Immunol Inflamm. 2019;27(4):524–527. doi:10.1080/09273948.2018.1483520.
  • Kim M. Vogt-Koyanagi-Harada Syndrome following influenza vaccination. Indian J Ophthalmol. 2016;64(1):98. doi:10.4103/0301-4738.178141.
  • Dansingani KK, Suzuki M, Naysan J, Samson CM, Spaide RF, Fisher YL. Panuveitis with exudative retinal detachments after vaccination against human papilloma virus. Ophthalmic Surg Lasers Imaging Retin. 2015;46(9):967–970. doi:10.3928/23258160-20151008-11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.